Plasma Fibulin-5 as a Novel Marker for Advanced Fibrosis in Chronic Hepatitis C.

阅读:2
作者:Yasui Yutaka, Sato-Matsubara Misako, Enomoto Masaru, Matsubara Tsutomu, Kosugi Mana, Inoue Kirara, Hoang Truong Huu, Yuasa Hideto, Fujii Hideki, Daikoku Atsuko, Ikura Yoshihiro, Kawamura Etsushi, Uchida-Kobayashi Sawako, Tamori Akihiro, Kawada Norifumi
BACKGROUND AND AIMS: Despite remarkable advances in the treatment of viral hepatitis, liver fibrosis sometimes persists after viral eradication. The accumulation of elastic fiber is associated with unfavorable clinical outcomes. We aimed to clarify the utility of plasma fibulin-5 (FBLN5), a component of elastic fibers, in assessing liver fibrosis in patients with chronic hepatitis. METHODS: We reviewed 90 patients with chronic hepatitis C who underwent liver biopsy. Using immunohistochemistry and in situ hybridization, we investigated the localization of FBLN5 and its correlation with α-smooth muscle actin (αSMA). We then analyzed mRNA and protein expression in human hepatic stellate cells (HHSteCs) and primary mouse stellate cells. Lastly, we evaluated the utility of plasma FBLN5 for predicting liver fibrosis in patients with hepatitis C. RESULTS: Immunohistochemical analysis revealed a correlation between the quantity of FBLN5 and αSMA (r = 0.65) as well as FBLN5 and fibrosis stage (r = 0.30). FBLN5 was localized to areas enriched for αSMA-positive cells. In situ hybridization confirmed the colocalization of FBLN5 mRNA with αSMA and desmin-positive cells. Single nuclear RNA-sequencing analysis revealed that FBLN5 expression is predominantly expressed in the hepatic stellate cell/fibroblast cluster in other etiology, and the expression level was higher in cirrhotic livers. FBLN5 was overexpressed in cultured HHSteCs in response to 2.0 μg/mL transforming growth factor-β1 (P < .001), with increased FBLN5 concentration in the medium of transforming growth factor-β1-treated activated HHSteC. FBLN5 upregulation was also confirmed in primary-cultured mouse stellate cells. Finally, plasma FBLN5 levels increased with fibrosis progression in patients with chronic hepatitis C (P < .001). CONCLUSION: FBLN5 may represent the activation of hepatic stellate cells, and plasma FBLN5 levels have the potential to predict advanced fibrosis, especially in fibrosis related to elastic fibers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。